Trial Profile
Pivotal study of Modufolin in patients with Osteosarcoma
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Arfolitixorin (Primary)
- Indications Osteosarcoma
- Focus Therapeutic Use
- 27 May 2016 New trial record